Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04330898
Other study ID # RMN01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 2, 2017
Est. completion date July 30, 2020

Study information

Verified date April 2020
Source Trialance SCCL
Contact Xavier Molina Figueras, PharmD, PhD
Phone + 34 689900009
Email xmolina@trialance.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The general objective of this registry is to study the number of patients carrying an implantable cardiac device that have an indication for an imaging diagnosis based on nuclear magnetic resonance. Is wanted to know the cause of the indication of the diagnostic test based on MRI.


Description:

MRI is currently infra indicated in patients with cardiac stimulation devices and for this reason, the request for this imaging technique in these patients is complicated and, often, the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis.

Current data indicate that, with cardiological control and maintaining basic safety precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter Defibrillators (ICD) that require it for clinical reasons, although it should be noted that currently, due to lack of data published, the absolute safety of an MRI in these patients and the protocol used in each case cannot be guaranteed.

This registry proposal is to have data of all patients implanted with Biotronik cardiac stimulation devices and evaluate how many of them have an indication for an MRI-based diagnostic test, how many of them are already undergoing this diagnostic test, how many are given an tomography as an alternative to avoid subjecting patients to an MRI


Recruitment information / eligibility

Status Recruiting
Enrollment 1248
Est. completion date July 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Patients carrying a cardiac stimulation device

- Patients able to understand the nature of the procedure

- Patients who give informed consent

Exclusion Criteria:

- Epicardial cables

- Abandoned cables

- Non-BIOTRONIK cables

- Age <18 years

- Pregnant and breastfeeding

- Subjects with irreversible brain damage caused by a pre-existing brain disease

- Heart transplant 6 months prior to recruitment or expected within the next 3 months

- Cardiac surgery 3 months prior to recruitment or planned for the next 3 months

- Life expectancy less than 12 months

Study Design


Related Conditions & MeSH terms

  • Implantable Cardiac Device. Patients With a NMR Indication

Intervention

Device:
Biotronik peacemakers, implantable cardioverter-defibrillators and cardiac resynchronizers
Any of these Biotronik cardiac stimulation devices with the Home Monitoring function activated for the remote control of patients

Locations

Country Name City State
Spain Hospital General de Alicante Alicante
Spain Hospital San Juan de Alicante Alicante
Spain Hospital de Cruces Barakaldo
Spain Hospital Clinic Barcelona
Spain Hospital de Bellvitge Barcelona
Spain Hospital San Pedro de Alcantara Cáceres Madrid
Spain Hospital de Poniente El Ejido Madrid
Spain Hospital Arquitecto Marcide Ferrol Madrid
Spain Hospital de Galdakano Galdakao Madrid
Spain Hospital Puerta de Hierro Madrid
Spain Hospital Virgen de la Victoria Málaga
Spain Hospital Costa del Sol Marbella
Spain Hospital de Orense Orense Madrid
Spain Hospital General de Asturias Oviedo Madrid
Spain Hospital Virgen del Puerto Plasencia Madrid
Spain Hospital de Puerto Real Puerto Real Madrid
Spain Hospital Parc Taul'i Sabadell Madrid
Spain Hospital Marques de Valdecilla Santander Madrid
Spain Hospital Rio Hortega Valladolid Madrid
Spain Hospital Universitatis de Araba Vitoria Madrid

Sponsors (1)

Lead Sponsor Collaborator
Trialance SCCL

Country where clinical trial is conducted

Spain, 

References & Publications (4)

Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994 Mar;96(3):200-9. — View Citation

Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, Peterson M, Ciuffo A, Lee S, Landborg L, Cerkvenik J, Kanal E; Evera MRI Study Investigators. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a R — View Citation

Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, Felmlee JP, Froelich JW, Hayden J, Kaminski EM, Lester JW Jr, Scoumis EA, Zaremba LA, Zinninger MD; American College of Radiology. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol. 2004 May;182(5):1111-4. — View Citation

Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006 Oct 10;175(8):911-7. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of patients with implantable cardiac devices that require a diagnostic test based on MRI statistical analysis of the variable 1 year
Secondary Primary indication for MRI statistical analysis of the variable 1 year
Secondary Reasons for not used MRI statistical analysis of the variable 1 year
Secondary Percentage of patients with a non-MRI-based test diagnosis, although they had an indication for an MRI-based diagnostic test because of their disease statistical analysis of the variable 1 year
Secondary Cost effectiveness of the he MRI Autodetect function statistical analysis of the variable 1 year
Secondary Analysis of the differences in the workflow statistical analysis of the variable 1 year